Results 51 to 60 of about 8,261 (192)

Neutralizing antibodies induced by homologous and heterologous boosters in CoronaVac vaccines in Chile [PDF]

, 2023
Objectives:To determine the impact of a booster dose on the humoral response in individuals inoculated with a complete schedule of any SARS-CoV-2 vaccine, we evaluated the neutralizing antibody (NAb) titres of homologous or heterologous booster doses ...
Rivas, Solange, Gaete-Argel, Aracelly, Soto-Rifo, Ricardo, Araos, Rafael, Valiente-Echeverría, Fernando, Acevedo, Johanna, González, Cecilia, Jara, Alejandro, Acevedo, Mónica L., Jarpa, Stephan, Pizarro, Pablo, Espinoza, Daniela   +11 more
core   +1 more source

The Third dose of CoronVac vaccination induces broad and potent adaptive immune responses that recognize SARS-CoV-2 Delta and Omicron variants

Emerging Microbes and Infections, 2022
The waning humoral immunity and emerging contagious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants resulted in the necessity of the booster vaccination of coronavirus disease 2019 (COVID-19).
Yuxin Chen, Lin Chen, Shengxia Yin, Yue Tao, Liguo Zhu, Xin Tong, Minxin Mao, Ming Li, Yawen Wan, Jun Ni, Xiaoyun Ji, Xianchi Dong, Jie Li, Rui Huang, Ya Shen, Han Shen, Changjun Bao, Chao Wu   +17 more
doaj   +1 more source

Immunogenicity and reactogenicity of heterologous prime-boost vaccination with inactivated COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccines, a quasi-experimental study

Human Vaccines & Immunotherapeutics, 2023
The global supply of COVID-19 vaccines has been limited, and concerns have arisen about vaccine supply chain disruptions in developing countries. Heterologous prime-boost vaccination, which involves using different vaccines for the first and second doses,
Kriangkrai Tawinprai, Pawornrath Jungsomsri, Onnicha Pinijnai, Fahsiri Tavonvunchai, Anchisa Lievjaroen, Paphada Suwannaroj, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, Gaidganok Sornsamdang, Teerapat Ungtrakul   +9 more
doaj   +1 more source

The Early-Term Adverse Effects in Healthcare Personnel after CoronaVac Vaccination

Journal of Contemporary Medicine, 2022
Objectives: Among the various Covidien-19 vaccine, Sinovac vaccination program in Turkey is carried out by coronavac vaccine developed by Chinese firms.
Mehmet Kabak, Barış Çil
doaj   +1 more source

ANALISIS PERBEDAAN KEJADIAN IKUTAN PASCA IMUNISASI (KIPI) VAKSIN CORONAVAC DOSIS PERTAMA DAN KEDUA PADA MASYARAKAT PROVINSI JAWA TENGAH [PDF]

, 2022
Kejadian ikutan pasca imunisasi (KIPI) vaksin coronavac masih banyak ditemukan di Indonesia terkhusus di Provinsi Jawa Tengah. Tujuan dari penelitian ini adalah untuk mengetahui perbedaan kejadian ikutan pasca imunisasi (KIPI) vaksin coronavac dosis ...
Banin, Syifa Audina
core   +1 more source

Lot-to-lot consistency, immunogenicity, and safety of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults: A randomized, double-blind, phase IV trial

Human Vaccines & Immunotherapeutics, 2022
Previous phase I to III clinical trials have shown that the inactivated SARS-CoV-2 vaccine namely CoronaVac has good efficacy, safety, and immunogenicity.
Dandan Zhu, Yuansheng Hu, Zhiwei Jiang, Tuantuan Yang, Kai Chu, Hengming Zhang, Jialei Hu, Xing Meng, Zhijun Tan, Jingliang Wu, Xiaojuan Lian, Changgui Li, Hongxing Pan   +12 more
doaj   +1 more source

Retinal artery occlusion following CoronaVac injection in a 45-year-old Filipino

GMS Ophthalmology Cases, 2023
Background: While complex public health challenges and the emergence of variants have impeded responses to the COVID pandemic, vaccines continue to represent a crucial tool in mitigating the risk of morbidity and mortality.
Mendoza, Daniel Jose M., Chan, David Francis F., Yu-Keh, Ellen N., Sy, Bryan Christopher W.   +3 more
doaj   +1 more source

Neutralizing activity of a third dose of CoronaVac against Omicron subvariants within a 20-month follow-up study

Human Vaccines & Immunotherapeutics, 2023
The durability of antibody responses induced by the three-dose of CoronaVac vaccination, especially against SARS-CoV-2 Omicron subvariants, remains unclear.
Cheng Cao, Qin Guo, Yaping Dai, Junfeng Jiang, Min Liu, Tuo Ji, Pengcheng Zhou, Fang Gong   +7 more
doaj   +1 more source

Cord blood antibody following maternal SARS-CoV-2 inactive vaccine (CoronaVac) administration during the pregnancy

Human Vaccines & Immunotherapeutics, 2021
Maternal vaccination with SARS-CoV-2 vaccines has not been well studied yet in terms of safety and efficacy for protecting the newborn by the placental passage of antibodies. We reported 34 years of old health care worker (HCW) without any known SARS-CoV-
Ahmet Soysal, Canan Bilazer, Erdem Gönüllü, Emine Barın, Mahmut Çivilibal   +4 more
doaj   +1 more source

Anaphylaxis is rare due to CoronaVac in a population of healthcare workers

Asia Pacific Allergy, 2022
Background CoronaVac, the first coronavirus disease 2019 vaccine administered in our country, was found safe in clinical trials. Objective We aimed to reveal the rate and features of CoronaVac vaccine-associated allergic reactions among vaccinated healthcare workers (HCWs) in real ...
Öztürk, Betül Özdel, Akdemir, İrem, Azap, Alpay, Çelik, Gülfem, Bavbek, Sevim, Mungan, Dilşad   +5 more
openaire   +2 more sources